Executive | Strategy | Execution | Commercialization | Transformative | Accelerator
Laurie is a veteran executive of the life sciences industry, with over four decades of leadership experience in healthcare technology developed and deployed across multiple markets including diagnostics, biotechnology, drug development, healthcare IT and medical devices.
She has a proven track record of global commercial transformative strategies leading to revenue growth, profitability, and global brand awareness. She is an engaged board member who can have an immediate impact while building long-term strategy including financing, merger, acquisition, IPO and exit strategies for the company. Laurie served on global strategic advisory board for Lavaa Health, a digital health platform and Pictor DX a human and animal health diagnostic platform. She is also a board member and strategic advisor for BioLizard a bioinformatics focused on drug/diagnostic development.
Previous executive roles, as CEO, President, Chief commercial office, Heilmann had several companies to successful exits, some of which are Crown Bioscience, Notable Labs, Image Metrix. She has served as a Board Director and Interim CEO for Notable Labs and as a Board Director for Agendia where she was Chair of the compensation and commercial sub-commitments.
Heilmann’s synthesis of global business, clinical research, and technological acumen is ideal for assessing needs and assembling strategically sound, high-value solutions for her board and advisor roles. Her multifaceted experience from concept to commercialization, and knowledge of life science technology, the FDA and sponsor requirements in North America and Europe. She is an active member of numerous industry organizations and holds a bachelor’s degree in science and business.